Evidence that formulations of the selective MAO-B inhibitor, selegiline, which bypass first-pass metabolism, also inhibit MAO-A in the human brain

  • Joanna S. Fowler
  • , Jean Logan
  • , Nora D. Volkow
  • , Elena Shumay
  • , Fred McCall-Perez
  • , Millard Jayne
  • , Gene Jack Wang
  • , David L. Alexoff
  • , Karen Apelskog-Torres
  • , Barbara Hubbard
  • , Pauline Carter
  • , Payton King
  • , Stanley Fahn
  • , Michelle Gilmor
  • , Frank Telang
  • , Colleen Shea
  • , Youwen Xu
  • , Lisa Muench

Research output: Contribution to journal › Article › peer-review

64 Scopus citations

Fingerprint

Dive into the research topics of 'Evidence that formulations of the selective MAO-B inhibitor, selegiline, which bypass first-pass metabolism, also inhibit MAO-A in the human brain'. Together they form a unique fingerprint.

Keyphrases

Neuroscience